scispace - formally typeset
A

Astrid Bjørkøy

Researcher at Norwegian University of Science and Technology

Publications -  24
Citations -  472

Astrid Bjørkøy is an academic researcher from Norwegian University of Science and Technology. The author has contributed to research in topics: Microbubbles & Targeted drug delivery. The author has an hindex of 8, co-authored 23 publications receiving 376 citations.

Papers
More filters
Journal ArticleDOI

Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy

TL;DR: In vivo FRET imaging is used to systematically investigate how drug–carrier compatibility affects drug release in a tumour mouse model and finds the drug's hydrophobicity and miscibility with the nanoparticles are two independent key parameters that determine its accumulation in the tumour.
Journal ArticleDOI

Cellular uptake of DNA-chitosan nanoparticles: the role of clathrin- and caveolae-mediated pathways

TL;DR: This work tailored chitosan to optimize it for transfection by synthesizing self-branched and trisaccharide-substituted chitOSan oligomers (SBTCO), which show superior transfections efficacy compared with linear chitposan (LCO).
Journal ArticleDOI

Ultrasound Improves the Delivery and Therapeutic Effect of Nanoparticle-Stabilized Microbubbles in Breast Cancer Xenografts.

TL;DR: A unique multifunctional drug delivery system consisting of microbubbles stabilized by polymeric nanoparticles (NPMBs), enabling ultrasound-mediated drug delivery is investigated, to determine if increased tumor uptake had a therapeutic benefit.
Journal Article

Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts.

TL;DR: The results indicate that the collagen network has a greater impact on the interstitial diffusion of macromolecules in tumour tissue than the hyaluronan gel.
Journal ArticleDOI

Ruthenium porphyrin-induced photodamage in bladder cancer cells

TL;DR: The present investigation of RuP-PDT showed that the dominating mode of cell death is necrosis, and RuP "dark toxicity" compared to the conventional chemotherapeutic drug cisplatin was higher, both evaluated by the MTT assay (24h).